Clinical Outcome of Carotid Body Paraganglioma Management: A Review of 10-Year Experience

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">Surgery</td><td class="align_center">19 cases (100%) transcervical approach</td></tr><tr><td class="align_left">RT</td><td class="align_center">2 cases (10.5%) metastatic to bone</td></tr><tr><td class="align_left">CTH</td><td class="align_center">1 case (5.3%) metastatic to lung</td></tr><tr><td class="align_left">RT/CTH</td><td class="align_center">1 case (5.3%) metastatic to lung and bone</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>Treatment modalities for carotid body paragangliomas.</div>

Journal of Oncology

tab2

Table 2

Table 2: Clinical Outcome of Carotid Body Paraganglioma Management: A Review of 10-Year Experience 